M. Anttila et al., Failure to demonstrate human papillomavirus DNA in epithelial ovarian cancer by general primer PCR, GYNECOL ONC, 72(3), 1999, pp. 337-341
One of the recent controversies with substantial clinical interest is the r
ole of HPV in pathogenesis of ovarian cancer. The available highly conflict
ing data are based on analysis of 175 ovarian carcinomas so far. As an atte
mpt to further elucidate this issue, the first systematic study of HPV dete
ction in ovarian cancer was carried out using a highly sensitive general pr
imer PCR (confirmed by hybridization for low- and high-risk HPV types separ
ately) in a series of 98 histologically and clinically well-characterized e
pithelial ovarian malignancies. Despite the high (fg) sensitivity and a wid
e HPV type coverage of the technique used, all 98 ovarian carcinomas failed
to demonstrate any signs of HPV DNA whatsoever. The preexisting 12 reports
comprising a total of 175 ovarian tumors analyzed for HPV were summarized,
giving highly discrepant results (i.e., detection rates from 0 to 100%) wi
th the overall HPV DNA detection rate of 25.7%. The reasons for these discr
epant findings are most probably technical. Our data are consistent with th
ose of the majority of the most recent reports failing to disclose HPV DNA
in ovarian neoplasia. The present completely negative results make the auth
ors inclined to conclude that HPV is highly unlikely to play any causal rol
e in the pathogenesis of epithelial ovarian neoplasia, (C) 1999 Academic Pr
ess.